D.E. Shaw & Co’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.5M Buy
1,609,635
+901,828
+127% +$41.2M 0.04% 516
2025
Q4
$31.4M Buy
707,807
+366,281
+107% +$15.8M 0.02% 971
2025
Q3
$14.4M Buy
341,526
+85,617
+33% +$3.45M 0.01% 1409
2025
Q2
$9.38M Buy
255,909
+65,831
+35% +$2.44M 0.01% 1544
2025
Q1
$7.24M Sell
190,078
-319,047
-63% -$11.9M 0.01% 1639
2024
Q4
$19.3M Buy
509,125
+123,689
+32% +$4.94M 0.01% 1055
2024
Q3
$15.7M Buy
385,436
+106,085
+38% +$4.01M 0.01% 1138
2024
Q2
$9.57M Buy
279,351
+198,621
+246% +$6.26M 0.01% 1355
2024
Q1
$2.56M Sell
80,730
-13,649
-14% -$415K ﹤0.01% 2438
2023
Q4
$2.89M Buy
94,379
+64,124
+212% +$2.06M ﹤0.01% 2368
2023
Q3
$1M Buy
30,255
+8,413
+39% +$269K ﹤0.01% 3054
2023
Q2
$670K Sell
21,842
-307
-1% -$8.87K ﹤0.01% 3291
2023
Q1
$607K Buy
22,149
+5,602
+34% +$156K ﹤0.01% 3458
2022
Q4
$462K Sell
16,547
-10,665
-39% -$322K ﹤0.01% 3889
2022
Q3
$802K Sell
27,212
-152,493
-85% -$4.78M ﹤0.01% 3741
2022
Q2
$5.07M Buy
179,705
+117,346
+188% +$3.34M 0.01% 2112
2022
Q1
$1.94M Sell
62,359
-251,548
-80% -$7.42M ﹤0.01% 3330
2021
Q4
$9.29M Sell
313,907
-1,149,860
-79% -$33.6M 0.01% 1726
2021
Q3
$43.9M Sell
1,463,767
-827,466
-36% -$28.5M 0.04% 588
2021
Q2
$83.1M Buy
2,291,233
+505,535
+28% +$18.8M 0.07% 329
2021
Q1
$65.4M Buy
1,785,698
+964,373
+117% +$35.5M 0.06% 374
2020
Q4
$29.8M Sell
821,325
-424,456
-34% -$14.4M 0.03% 748
2020
Q3
$37.3M Buy
1,245,781
+136,932
+12% +$4.28M 0.04% 537
2020
Q2
$33M Buy
1,108,849
+709,016
+177% +$21M 0.04% 532
2020
Q1
$10.6M Buy
+399,833
New +$15.2M 0.02% 962
2019
Q3
Sell
-11,500
Closed -$448K 3958
2019
Q2
$423K Sell
11,500
-13,471
-54% -$491K ﹤0.01% 3147
2019
Q1
$953K Sell
24,971
-368,425
-94% -$13.7M ﹤0.01% 2636
2018
Q4
$13.8M Buy
+393,396
New +$13.6M 0.02% 898
2018
Q1
Sell
-63,735
Closed -$1.75M 3706
2017
Q4
$1.75M Sell
63,735
-42,691
-40% -$1.23M ﹤0.01% 2230
2017
Q3
$3.4M Sell
106,426
-117,297
-52% -$3.76M 0.01% 1668
2017
Q2
$7.39M Sell
223,723
-686,508
-75% -$22.7M 0.01% 1071
2017
Q1
$30M Sell
910,231
-377,172
-29% -$12.1M 0.05% 427
2016
Q4
$40.2M Buy
1,287,403
+1,278,097
+13,734% +$39.4M 0.07% 371
2016
Q3
$330K Sell
9,306
-246,494
-96% -$8.76M ﹤0.01% 3005
2016
Q2
$8.68M Sell
255,800
-211,080
-45% -$7.04M 0.02% 963
2016
Q1
$16.5M Buy
466,880
+458,496
+5,469% +$15M 0.03% 624
2015
Q4
$293K Sell
8,384
-8,000
-49% -$276K ﹤0.01% 3374
2015
Q3
$576K Buy
+16,384
New +$575K ﹤0.01% 2968
2014
Q1
Sell
-17,207
Closed -$513K 4516
2013
Q4
$513K Sell
17,207
-38,909
-69% -$1.23M ﹤0.01% 3715
2013
Q3
$1.68M Sell
56,116
-9,119
-14% -$277K ﹤0.01% 2578
2013
Q2
$2.02M Buy
+65,235
New +$2.14M ﹤0.01% 2104

Other funds holding OHI

D.E. Shaw & Co's OHI Position: Q1 2026 in Review

D.E. Shaw & Co increased its Omega Healthcare (OHI) stake by 127% in Q1 2026, buying an estimated $41.2M and bringing the position to 1,609,635 shares worth $70.5M. The position accounts for 0.04% of the portfolio, ranked #516.

D.E. Shaw & Co first reported a position in OHI in Q2 2013 and has held it in 41 quarters since. The position peaked at $83.1M in Q2 2021. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • D.E. Shaw & Co held 1,609,635 shares of Omega Healthcare worth $70.5M as of Q1 2026.
  • D.E. Shaw & Co bought 901,828 Omega Healthcare shares in Q1 2026, an estimated $41.2M.
  • Omega Healthcare made up 0.04% of D.E. Shaw & Co's portfolio in Q1 2026, its #516 holding.
  • D.E. Shaw & Co first reported a position in Omega Healthcare in Q2 2013 and has held it in 41 quarters since.
  • D.E. Shaw & Co's Omega Healthcare position peaked at $83.1M in Q2 2021.
  • 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.